KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Exchange Rate Effect (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Exchange Rate Effect data on record, last reported at $3.5 million in Q4 2025.

  • For Q4 2025, Exchange Rate Effect fell 93.14% year-over-year to $3.5 million; the TTM value through Dec 2025 reached -$44.8 million, down 216.06%, while the annual FY2025 figure was -$44.8 million, 216.06% down from the prior year.
  • Exchange Rate Effect reached $3.5 million in Q4 2025 per EW's latest filing, up from -$1.0 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $51.0 million in Q4 2024 and bottomed at -$51.5 million in Q3 2024.
  • Average Exchange Rate Effect over 5 years is $2.2 million, with a median of $2.6 million recorded in 2021.
  • The widest YoY moves for Exchange Rate Effect: up 1960.0% in 2022, down 1111.11% in 2022.
  • A 5-year view of Exchange Rate Effect shows it stood at $1.8 million in 2021, then plummeted by 1111.11% to -$18.2 million in 2022, then soared by 81.32% to -$3.4 million in 2023, then surged by 1600.0% to $51.0 million in 2024, then tumbled by 93.14% to $3.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were $3.5 million in Q4 2025, -$1.0 million in Q3 2025, and -$29.6 million in Q2 2025.